Steven Lichtman
Stock Analyst at William Blair
(4.74)
# 644
Out of 4,456 analysts
990
Total ratings
53%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED MiniMed Group | Maintained: Buy | n/a | $14.24 | - | 2 | Jun 17, 2026 | |
| COO The Cooper Companies | Maintained: Buy | n/a | $71.02 | - | 30 | Jun 5, 2026 | |
| PODD Insulet | Maintained: Buy | n/a | $158.25 | - | 64 | Jun 4, 2026 | |
| GKOS Glaukos | Maintained: Buy | n/a | $144.42 | - | 14 | Jun 3, 2026 | |
| DXCM DexCom | Maintained: Buy | n/a | $70.14 | - | 89 | May 15, 2026 | |
| ENOV Enovis | Maintained: Buy | n/a | $22.71 | - | 2 | May 8, 2026 | |
| RXST RxSight | Maintained: Hold | n/a | $5.36 | - | 15 | May 8, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | n/a | $5.69 | - | 3 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | n/a | $55.20 | - | 7 | May 6, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $332.71 | - | 52 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $93.10 | - | 72 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $15 | $4.14 | +262.32% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 | $44.23 | +166.79% | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7.5 | $14.48 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $78 | $86.25 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $116 | $71.73 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $16 | $13.40 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $316.63 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $29.29 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $94 | $80.98 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $16.24 | n/a | 43 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.76 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $4.94 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.43 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.73 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.20 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $282.79 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6185 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.30 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.72 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.68 | n/a | 1 | Oct 7, 2011 |
MiniMed Group
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $14.24
Upside: -
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $71.02
Upside: -
Insulet
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $158.25
Upside: -
Glaukos
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $144.42
Upside: -
DexCom
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $70.14
Upside: -
Enovis
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $22.71
Upside: -
RxSight
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $5.36
Upside: -
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.69
Upside: -
Alcon Inc.
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $55.20
Upside: -
Stryker
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $332.71
Upside: -
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $93.10
Upside: -
Sep 5, 2025
Maintained: Buy
Price Target: $12 → $15
Current: $4.14
Upside: +262.32%
Aug 3, 2025
Maintained: Hold
Price Target: $118
Current: $44.23
Upside: +166.79%
May 14, 2025
Maintained: Buy
Price Target: $11 → $7.5
Current: $14.48
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $73 → $78
Current: $86.25
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $87 → $116
Current: $71.73
Upside: n/a
Jan 10, 2025
Maintained: Buy
Price Target: $13 → $16
Current: $13.40
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $316.63
Upside: n/a
Nov 1, 2024
Maintained: Hold
Price Target: n/a
Current: $29.29
Upside: n/a
Aug 21, 2024
Maintained: Hold
Price Target: $92 → $94
Current: $80.98
Upside: n/a
Aug 2, 2024
Maintained: Buy
Price Target: $58
Current: $16.24
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $18.76
Upside: n/a
Sep 19, 2023
Maintained: Buy
Price Target: $3.5
Current: $4.94
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.43
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $1.73
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $7.20
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $282.79
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $0.6185
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $3.30
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.72
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.68
Upside: n/a